ACET
Adicet Bio Inc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website adicetbio.com
- Employees(FY) 132
- ISIN US0070021086
Performance
-1.84%
1W
-26.94%
1M
-45.58%
3M
+36.75%
6M
-15.34%
YTD
-76.01%
1Y
Profile
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and chimeric adaptors to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also develops ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors; and ADI-925, a novel engineered CAd gamma delta T cell product candidate targeting tumor stress ligands. Adicet Bio, Inc. is based in Boston, Massachusetts.
Technical Analysis of ACET 2024-05-10
Overview:
In analyzing the technical indicators for ACET over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the c...
Recent News & Updates
- 2024-05-14 09:54
ACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024(Investorplace)
- 2024-05-14 04:01
- 2024-05-13 22:00
- 2024-05-13 22:00
- 2024-05-06 19:00
- 2024-04-30 05:10
- 2024-04-22 04:30
- 2024-04-07 19:00
- 2024-04-03 20:38
- 2024-03-31 21:40
- 2024-03-28 05:19
- 2024-03-21 21:35
- 2024-03-19 09:53
ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023(Investorplace)
- 2024-03-19 04:10
- 2024-03-14 21:40
- 2024-03-10 19:00
- 2024-02-29 06:46
- 2024-02-27 20:40
- 2024-02-11 20:40
- 2024-02-05 03:01
- 2024-01-31 03:39
- 2024-01-29 23:51
- 2024-01-25 03:01
- 2024-01-24 20:40
- 2024-01-22 10:43
Adicet Bio, Inc. Announces Pricing of Public Offering(Businesswire)
- 2024-01-22 03:28
Adicet Bio, Inc. Announces Proposed Public Offering(Businesswire)
- 2024-01-03 18:00
- 2024-01-03 03:01
- 2023-12-29 03:50
- 2023-12-09 23:00
Page 1 of 4
previousnext